Orthopedic surgeons and researchers found that platelet-rich plasma can produce improvement in patients who suffer from elbow injury after conservative treatments fail, according to a news release from the American Orthopaedic Society for Sports Medicine.
A research team led by Scott A. Crow, MD, of Kerlan-Jobe Orthopaedic Clinic in Los Angeles, followed 17 athletes with a partial ulnar collateral ligament tear. The patients failed conservative treatment. Each patient completed baseline pain and disability tests before undergoing a single PRP injection with ultrasound guidance.
After an average of 18 weeks, 16 of the athletes returned to play. The average return-to-play time was 10 weeks and the average Kerlan-Jobe Shoulder and Elbow Score improved from 47 to 93. The average Disability of the Arm, Shoulder and Hand Score improved from 24 to three.
Related Articles on Sports Medicine:
Cartilage Transplant Procedures Can Return Athletes to Play Better Than Microfracture
Lemak Sports Medicine and Orthopedics Opens New Alabama Office
Hospital for Special Surgery Study Shows Learning Curve for ACL Reconstruction
After an average of 18 weeks, 16 of the athletes returned to play. The average return-to-play time was 10 weeks and the average Kerlan-Jobe Shoulder and Elbow Score improved from 47 to 93. The average Disability of the Arm, Shoulder and Hand Score improved from 24 to three.
Related Articles on Sports Medicine:
Cartilage Transplant Procedures Can Return Athletes to Play Better Than Microfracture
Lemak Sports Medicine and Orthopedics Opens New Alabama Office
Hospital for Special Surgery Study Shows Learning Curve for ACL Reconstruction